Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is $3.03 billion. Endo Health's PEG ratio is 0.90.The trailing-twelve-month revenue at Warner Chilcott plc (NASDAQ: WCRX) is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter.The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!